Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Nucor    NUE

My previous session
Most popular
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweetsMarketScreener Strategies

Nucor : In an accumulation phase

share with twitter share with LinkedIn share with facebook
share via e-mail
09/12/2018 | 02:37pm CET
long trade
Stop-loss triggered
Entry price : 62.96$ | Target : 69.35$ | Stop-loss : 59.7$ | Potential : 10.15%
An exit from the recently observed accumulation phase to the upside could allow for the assumption that a clear upward trend is re-established with an increase in volatility.
Investors have an opportunity to buy the stock and target the $ 69.35.
Duration : Period :
Nucor Technical Analysis Chart | MarketScreener
Full-screen chart
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.

  • Historically, the company has been releasing figures that are above expectations.
  • As regards fundamentals, the enterprise value to sales ratio is at 0.86 for the current period. Therefore, the company is undervalued.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • Sales forecast by analysts have been recently revised upwards.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.

David Meurisse
© Zonebourse.com 2018
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials ($)
Sales 2018 25 108 M
EBIT 2018 3 419 M
Net income 2018 2 361 M
Debt 2018 1 775 M
Yield 2018 2,40%
P/E ratio 2018 8,52
P/E ratio 2019 10,02
EV / Sales 2018 0,86x
EV / Sales 2019 0,83x
Capitalization 19 850 M
Upcoming event on NUCOR
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 75,9 $
Spread / Average Target 20%
EPS Revisions
John J. Ferriola Chairman, President & Chief Executive Officer
James D. Frias Chief Financial Officer, Treasurer & Executive VP
Victoria Franchetti Haynes Independent Director
John H. Walker Lead Independent Director
Christopher J. Kearney Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
NUCOR-1.15%19 850
ARCELORMITTAL-19.73%25 191
POSCO--.--%19 893
SEVERSTAL' PAO--.--%13 026